Abstract
Cancer is a serious public issue problem worldwide. In Brazil, breast cancer is the most common type and cervical cancer is the third most frequent among women. To analyze the temporal trend of coverage of mammography and cervical oncotic cytological testing, between 2007 and 2018. Time-series study conducted in the 26 Brazilian state capitals and in the Federal District. A linear regression model was used to estimate trends in coverage of mammography and cervical oncotic cytological testing over the period. The data collection system for Surveillance of Risk and Protection Factors for Chronic Diseases by Telephone Survey (Vigitel) was used. A significant increase in mammography coverage was observed, from 71.1% in 2007 to 78.0% in 2018. There was a trend towards an increase among women with 0 to 8 years of schooling, in all regions of Brazil. Regarding cervical oncotic cytological testing coverage, there was a trend towards stability during the period analyzed, reaching 81.7% in 2018. On the other hand, there was a significant increase in the northern region. There was an improvement in the coverage of these screening examinations, especially regarding mammography. However, it is still necessary to expand their provision, quality and surveillance, aimed towards women's health.
Highlights
Cancer is a serious public health issue worldwide
Vigitel is a survey conducted through telephone calls in the Brazilian population, which annually monitors the main chronic noncommunicable diseases (NCDs) and their risk and protection factors
This survey is conducted on a representative sample of the adult population in Brazil (≥ 18 years old) living in households with at least one fixed telephone line, in each of the 26 Brazilian state capitals and in the Federal District
Summary
Cancer is a serious public health issue worldwide. Brazil is expected to have 66,280 cases of breast cancer diagnosed per year between 2020 and 2022, corresponding to a rate of 61.6 diagnoses per 100,000 women. The number of new cervical cancer cases expected for the same period would be 16,590, corresponding to a rate of 15.43 per 100,000 women.[1]. OBJECTIVE: To analyze the temporal trend of coverage of mammography and cervical oncotic cytological testing, between 2007 and 2018. METHODS: A linear regression model was used to estimate trends in coverage of mammography and cervical oncotic cytological testing over the period. Regarding cervical oncotic cytological testing coverage, there was a trend towards stability during the period analyzed, reaching 81.7% in 2018. It is still necessary to expand their provision, quality and surveillance, aimed towards women’s health
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
